PRSS3 and neoplasm: Notably, our findings revealed that C2 UBE2C+ tumour cells had stronger efferent signals in the PARs signalling pathway, and actively interacted with pericytes, fibroblasts and endothelial cells, and high expression levels of the involved signalling gene PRSS3.